February 2, 2017
February 2, 2017 —
…Davis have received a $2 million grant from the Patient-Centered Outcomes Research Institute (PCORI) for a three-year study to look at the effectiveness of two treatment options for children with KD who are resistant to initial therapy.
November 16, 2012
November 16, 2012 —
…is this year’s American Cancer Society “Pathfinder in Palliative Care” honoree. The award – which recognizes individuals who have demonstrated innovation and ingenuity in their contributions to the advancement of the field of palliative care – was presented today at the Society’s Nationwide Volunteer and Staff Leadership Summit in Atlanta.
October 31, 2023
October 31, 2023 —
UC San Diego Health provides the highest standards of care by multi-disciplinary teams from expectant parents to patients going through menopause.
August 4, 2016
August 4, 2016 —
…— on May 20, 2016, Legaspi became the first patient in San Diego to receive a new type of immunotherapy, known as CAR T-cell therapy, as part of a Phase I/II clinical trial at Moores Cancer Center at UC San Diego Health.
July 20, 2015
July 20, 2015 —
Once again, UC San Diego Health and its hospitals are ranked #1 in San Diego, and recognized among the best in the nation, by U.S. News & World Report for 2015-16. The annual U.S. News “Best Hospitals” rankings distinguish hospitals that excel in treating the most challenging health conditions.
June 13, 2012
June 13, 2012 —
…genes, but may also improve diagnoses and guide individual patient care.
April 22, 2019
April 22, 2019 —
University of California San Diego School of Medicine researchers found that treating patients with personalized precision medicine that combined therapies to target multiple alterations improved outcomes in patients with therapy resistant cancers.
April 9, 2013
April 9, 2013 —
As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.
August 24, 2021
August 24, 2021 —
After more than 50 days on advanced life support, a multi-disciplinary team at UC San Diego Health helps a patient who contracted COVID-19 become a candidate for a successful double lung transplant. The transplant surgery was the first in the region performed on a COVID-19 patient.
September 17, 2020
September 17, 2020 —
A consortium of 12 health systems, led by UC San Diego Health, introduces COVID19questions.org, a site where clinicians, researchers, patients and the general public are invited to submit questions that could be answered by COVID-19 patient medical record data from 200+ hospitals.